Completed

APS Foundation: 2025 STEM Education Grants - Spring Cycle

Limit: 2 // Tickets Available: 0

D. Stover (Molecular and Cellular Biology) 
J. Barton (BIO5 Institute)

The submission of this funding program is coordinated by RSD with the assistance of the University of Arizona Foundation. For more information, please contact Selena Valencia-Salazar. 

The APS Foundation supports programs that enhance academic achievement in the areas of science, technology, engineering and math (STEM). Since 1981, the Foundation has invested more than $44 million in projects throughout Arizona that help prepare students to compete in a 21st century economy.

A workforce proficient in STEM skills is critical to attracting and retaining high-quality businesses and industries to the state. The APS Foundation targets projects that help educators increase content knowledge in STEM subjects as well as the ability to transfer this knowledge effectively to students.

This program is funded by APS shareholders and not included in customer rates.

Program Information: 

  • Organizations must be registered as a 501(c)(3) public charity in good financial and public standing.
  • Programs should demonstrate their ability to improve educational outcomes, increase access and/or offer an innovative approach to learning.
  • Programs that support teacher professional development is APS Foundation’s primary focus.
  • Programs that impact students, supporting them in achievements in STEM, are the next priority.
  • Pilot projects may be funded, and those awards are generally in the $10,000 = $30,000.
  • Programs requesting substantial funding (≥$75,000) should demonstrate proof of concept, detailed budget, and have a detailed execution plan.
  • Strong measurements for proof of success are essential, especially for higher dollar asks. (At minimum, a pre, during, and post survey or variation of measurement will be required) 
  • Criteria used for evaluation include sustainability, ability to leverage other funding (not required).
  • Programs that serve underserved/under resourced students are well-received.
  • All grantees will have specific reporting requirements and must submit a final evaluation before they can be considered for additional funding.

 

Proposal Tips: 

  • Proposals should be written in lay language.
  • Multi-year funding is not available.
  • New interest in board for AI components in proposals (not required)
  • Higher asks will be scrutinized at a higher level. Please ensure you have a solid description, strong success measurements, and have an established program/project for best chance of being successful.
  • Proposals that involve medical themes are discouraged from applying as the funder has a separate initiative dedicated to medical themes/programming.
  • Seed funding applicants should consider the following questions: What will be measured for the ethicality of the program? What is guiding the assumption for need/success of your proposed project/proposal?  
Research Category
Funding Type
Internal Deadline
External Deadline
02/28/2025
Sponsor
Solicitation Type

HRSA-25-076 Scholarships for Disadvantaged Students

Please email your ADR if you are interested in applying for this funding opportunity. 

The University of Arizona may submit multiple applications; however, only one application may be submitted per one health profession degree program.

 

 

 
Funding Type
Internal Deadline
External Deadline
02/19/2025

2025 Damon Runyon Clinical Investigator Award

No Applicants // Limit: 5 // Tickets Available: 5


The University of Arizona Cancer Center (UACC) can nominate five applications for the Damon Runyon Clinical Investigator Award

For more information please contact: UACC-PreAward.

Purpose of Award 

The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine.

The Clinical Investigator Award responds to three recognized realities:

  • Though there has never been a more pressing need or more promising time for clinical cancer research, fewer young physicians enter this area of investigation every year.
  • The number of institutions committed to training young physicians in the scientific discipline and methodologies of clinical investigation is critically low.
  • The burden of medical school debt (averaging over $100,000) discourages many physicians from pursuing clinical investigation.

The Damon Runyon Cancer Research Foundation’s award offers solutions to these realities. The awardee will receive financial support for three years, as well as assistance with certain research costs such as the purchase of equipment. The Foundation will also retire up to $100,000 of any medical school debt still owed by the awardee.

The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.

 

Eligibility

  • The applicant must hold an independent Assistant Professor position or equivalent at a U.S. institution and is expected to demonstrate significant support from the home institution through a comprehensive start-up package, ample laboratory space, and protected research time, for example.
  • The applicant must have received an MD, DO, or MD/PhD degree(s) from an accredited institution, completed their subspecialty training and be U.S. Board eligible.
  • The applicant must hold a valid, active U.S. medical license at the time of application.
  • The applicant must apply within the first five (5) years of their Assistant Professor or equivalent full faculty appointment (Cut-off date: July 1, 2020). Instructor, Adjunct and/or acting positions are not eligible.
  • Candidates holding or awarded R01s (or R01-equivalent grants such as the DP2 and DP5) at the time of application are not eligible to apply.
  • The applicant must commit to spending 80% of their time conducting research. [In rare unique circumstances, the CIA Committee may consider an applicant with a very modest reduction of 80% protected time if their Department Chair can provide a compelling reason explaining why a waiver of the 80% requirement should be granted, what percentage of effort will be guaranteed, and what safeguards will be put in place to make sure the individual’s research will not be compromised by their clinical/administrative activities.]
  • The applicant is required to apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time (including Co-Mentors).
  • Candidates may apply up to two times during this eligibility period.
  • Only one application will be accepted from a Mentor per review session (including Co-Mentors).
Funding Type
Internal Deadline
External Deadline
2/3/2025

Farmer-to-Farmer Promoting Agricultural Volunteer Engagement and Support (PAVES)

Limit: 1 // Tickets Available: 1

Only one Concept note per organization/institution will be accepted

Funding Opportunity Description
The USAID John Ogonowski and Doug Bereuter Farmer-to-Farmer Program (F2F) promotes sustainable, broad-based economic growth in the agricultural sector as well as understanding by the public -- both in the United States and overseas -- of the importance of international development issues and the role of USAID in addressing them. F2F introduces innovation and develops local capacity for more productive, profitable, sustainable and equitable agricultural systems while providing opportunity for people-to-people interaction in agricultural development activities. F2F has four main objectives:

  • Increase agricultural sector productivity and profitability;
  • Improve conservation and sustainable use of environmental and natural resources; 
  • Expand agricultural sector access to financial services; and/or 
  • Strengthen agricultural sector institutions.  

F2F Programs build institutions and transfer technology and management expertise to link small farmers with markets that exploit comparative advantages in production, processing and marketing. Activities are varied and conform to country needs and strategic objectives. Specific F2F projects align with or support USAID Mission strategies and objectives or those of other USG programs in a given country.  

Internal Deadline
External Deadline
12/20/2024 at 6PM EST

U.S. Nuclear Regulatory Commission Research and Development Grant, Fiscal (FY) 2025

Tickets: 3 // Tickets Available: 2

T. Bheemasetti (Civil Arch Engr and Mechanics) 

Executive Summary
The U.S. Nuclear Regulatory Commission (NRC) is an independent agency, established by the Atomic Energy Act of 1954, as amended, tasked with licensing, and regulating the Nation’s civilian use of byproduct, source, and special nuclear material to ensure adequate protection of public health and safety, to promote the common defense and security, and to protect the environment.

The program provides funding to support research and development (R&D) for nuclear science, engineering, technology, and related disciplines to develop a workforce capable of supporting the design, construction, operation, and regulation of nuclear facilities and the safe handling of nuclear materials. University R&D activities provide an opportunity to complement current, ongoing NRC-led research. More specifically, the program shall be used to provide financial assistance for R&D projects relevant to the programmatic mission of the NRC referenced above, with an emphasis on providing federal financial assistance with respect to research, development, demonstration, and commercial application of new and advanced nuclear technologies. Social science research will be considered under this announcement (for example, projects that would foster the development of innovative community engagement strategies, including incorporation of principles of equity and environmental justice).

The NRC invites R&D projects that complement its current research portfolio and that help the NRC prepare for upcoming challenges. A summary of NRC research activities can be found at NRC Research Activities in the FY22-24 Research Prospectus. The NRC seeks projects that provide a variety of direct and indirect, near- and long-term outcomes. These outcomes include:
 

  • Identification and closure of potentially important technical gaps ahead of
    regulatory needs,
  • Heightened awareness and knowledge of key advanced technology
    developments being pursued outside of NRC, and
  • Improved foundational knowledge on key topics of future regulatory interest.
     

Number of Applications

An institution may submit no more than three (3) applications in response to this
announcement.
 

Although the Primary Investigator (PI)s prepare the grant application and are responsible for conducting and supervising the research, the actual applicant is the educational institution. The same PIs may not be on more than one application. A PI may not be a Co-PI on another application in response to this announcement.
 

An application in response to this announcement may include more than one Co-PI. However, an individual can only be proposed as a Co-PI within one (1) application in response to this announcement.

Funding Type
Internal Deadline
External Deadline
1/31/2025
Solicitation Type

NAT-RD-24-0003 PFAS Reduction and Innovation in Semiconductor Manufacturing (PRISM) Call for Proposals (CFP)

Limit: 2* // Tickets Available: 0

Wastewater Focus Area - Limit: 1 // Tickets Available: 0
S. Savagatrup (Chemical and Environmental Engineering)

Air Focus Area - Limit: 1 // Tickets Available: 0
M. Phillips (Wyant College of Optical Sciences) 

The submission for this funding program is coordinated by the Center for Semiconductor Manufacturing.Please contact Dan Moseke, Project Director, for more information.

Limit: 
An organization may only lead up to two proposals maximum (one for each Focus Area - air and wastewater) but may participate on more than one team. 
 

Concise Description of Funding Opportunity: 
NSTC’s PRISM program aims to enhance the sustainability of semiconductor manufacturing by addressing the challenges posed by per- and polyfluoroalkyl substances (PFAS) usage. The objective of the PRISM program is the successful creation of end-to-end PFAS mitigation capabilities, integrating advanced analytical methods, abatement technologies, and predictive modeling to address the environmental impact of PFAS usage in semiconductor manufacturing. 

Funding Type
Internal Deadline
External Deadline
12/04/2024 (concept paper)

PAR-25-061 Biomedical Research Facilities (C06 Clinical Trial Not Allowed)

Tickets: 1 // Tickets Available: 0 

D. Bhattacharya (Center for Advanced Molecular and Immunological Therapies)

Funding Opportunity Purpose 
This Notice of Funding Opportunity (NOFO) invites applications from eligible academic and research institutions to apply for funding to modernize existing or construct new biomedical research facilities. Applications will be accepted from public and private nonprofit institutions of higher education, as well as from non-profit research organizations. Applications from both research-intensive institutions and Institutions of Emerging Excellence (IEE) in biomedical research from all geographic regions in the nation are strongly encouraged.

NIH recognizes the importance of all institutions of higher learning in contributing to the nation’s research capacity from either research-intensive or low-resourced institutions. The goal of this NOFO is to modernize biomedical research infrastructure to strengthen biomedical research programs. Each project is expected to produce substantial long-term improvements to the institutional research infrastructure. Intended projects are the construction or modernization of core facilities and the development of other shared research infrastructure serving an institution-wide research community with broad impact on biomedical research. 

Number of Applications

Only one application per institution (identified by NIH IPF number) is allowed.

NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application.  This means that the NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Moreover, institutions with C06 awards funded under the Biomedical Research Facility Program (NOFOs PAR-22-088 , PAR-23-045, or PAR-23-306) are not eligible to apply to this NOFO, provided the awards are active on the receipt date for this NOFO. Thus, only one C06 Biomedical Research Facility active award per institution would be allowed at any given time.

Internal Deadline
External Deadline
12/16/2024 LOI

2025 St. Baldrick's Foundation - Research, Scholar, and International Scholar Grants

Limit: 3* // Tickets Available: 2

* Limit one ticket per category: 
 - Research Grant: Limit: 1 // Available: 0 
K. Huntoon (Neurosurgery)
- Scholar (CDA): Limit: 1 // Available: 1
- International Scholar Limit: 1 // Available: 1

The St. Baldrick’s Foundation works hard to be sure that every dollar makes the biggest impact possible in childhood cancer research. The Foundation is proud to have received the National Cancer Institute Peer Review Funder designation for selection of grants. The Foundation has held several Research Priorities Summits with many of the country’s leading pediatric oncology researchers participating to advise the staff and board of directors on funding priorities.
The St. Baldrick’s team and scientific advisors meet regularly to be sure St. Baldrick’s
funds make the greatest impact on pediatric cancer research.

Current funding priorities are divided into four categories:

  • New discovery research
  • Translational research and early phase clinical trials
  • Phase III clinical trials & infrastructure support of participating institutions
    (primarily the fall grant cycle)
  • Education of new pediatric oncology researchers
     


In addition to research to understand the biology of childhood cancers and discover
leads to more effective treatments, topics of interest include, but are not limited to:

  • Adolescents & young adults
  • Survivorship, outcomes, and quality of life
  • Supportive care
  • Epidemiology and pediatric cancer predispositions
  •  Precision medicine
  • Alternative & complementary therapies
Internal Deadline
External Deadline
2/28/2025
Solicitation Type

CMI-1-2024: Critical Materials Innovation Hub

Limit: 1 // Tickets Available: 0

S. Ndlovu (Mining and Geological Engineering) 

Limited Submission Eligibility
Lead Organizations are limited to one submission. No limits on partnering as sub-recipients.

Purpose and Objectives
The intent of this Request for Proposals (RFP) is to seek out new opportunities to accelerate the transformational advances in science and engineering necessary to reduce material criticality for energy innovation, with specific emphasis on industrial relevance, participation, and adoption. Additionally, CMI seeks projects that strengthen and expand its R&D portfolio by developing the capabilities and expertise across supply chain stages of materials contained in CMI materials scope. The current materials scope within CMI is summarized as shown in Table 1. It specifies whether the initial Phase III research efforts are directed toward process innovation, material innovation, or a combination of both. CMI materials scope includes magnetic rare earth elements, energy storage materials, platinum group metals, and gallium, germanium and tellurium. The current R&D profile reflects CMI’s strategic plan and vision (as informed by CMI Phase III Roadmap) to address challenges across four broadly defined parts of the supply chain: upstream, midstream, downstream, and materials innovation.
 

Cost Share Requirement
Cost share (20% minimum) required for matching federal support of private sector industrial team members. A minimum of 20% cost share of total project costs is encouraged. 

Funding Type
Internal Deadline
External Deadline
12/20/2024

NSF 24-599: Quantum Leap Challenge Institutes (QLCI)

Limit: 2 // Tickets Available: 0

J. Schaibley (Physics) 
I. Djordjevic (Electrical & Computer Engineering)

Subcontract/Non-lead organizational Proposals // Not Limited 
D. Hahn (Engineering) - subcontract to the University of Oklahoma 

Limit on Number of Proposals per Organization: 2

Limitations on the number of proposals per organization do not apply to the Letters of Intent.

Lead organizations are limited to submit no more than two (2) Challenge Institute Preliminary Proposals. Lead organizations are limited to submit no more than two (2) invited Challenge Institute Full Proposals. Multi-institutional Challenge Institute proposals must be submitted as a single proposal by a single lead organization; separately submitted collaborative proposals are not permitted.


Letter of Intent Due Date(s) (required) (due by 5 p.m. submitting organization's local time):

     February 07, 2025

Preliminary Proposal Due Date(s) (required) (due by 5 p.m. submitting organization's local time):

     March 07, 2025

Full Proposal Deadline(s) (due by 5 p.m. submitting organization's local time):

     September 17, 2025

Synopsis of Program:

Quantum Leap Challenge Institutes are large-scale interdisciplinary research projects motivated by major challenges at the frontiers of quantum information science and technology (QIST). Institutes are expected to catalyze breakthroughs on important problems underpinning QIST, for example in the focus areas of quantum computation, quantum communication, quantum simulation and/or quantum sensing. Successful institutes will coordinate a variety of approaches to specific scientific, technological, and educational goals in these fields, including multiple institutions and building upon multiple disciplines, as motivated by the science and engineering challenges. In so doing, Institutes will nurture a culture of discovery, provide education, training, and workforce development opportunities in the context of cutting-edge research, and demonstrate value-added from synergistic coordination within the institute and with the broader community. Partnerships, infrastructure, industry engagement, outreach, international collaboration, and new applications for QIST should be fostered by Institutes in support of their research, education, and coordination goals.

The QLCI program can support awards to continue existing Quantum Leap Challenge Institutes or to establish and operate new Quantum Leap Challenge Institutes. In either case, proposers should follow the same guidance for Challenge Institute proposal preparation described in this solicitation. While this is a crosscutting program, proposals responding to this solicitation must be submitted to the Office of Strategic Initiatives (OSI) in the Directorate of Mathematical and Physical Sciences (MPS). They will subsequently be managed by a cross-disciplinary team of NSF Program Directors.

The QLCI program enables NSF multidisciplinary centers for quantum research and education as called for in the National Quantum Initiative (NQI) Act1 and an NQI Advisory Committee report, Renewing the National Quantum Initiative: Recommendations for Sustaining American Leadership in Quantum Information Science2.In alignment with the NQI Act, Quantum Leap Challenge Institutes shall pursue research at the frontiers of quantum information science, engineering, and technology, and explore solutions to important challenges for the development, application, commercialization, and pioneering use of quantum technologies. QLCI Institutes shall also lead education, training, and workforce development activities as may be needed for sustained leadership in QIST and related topics. Coordination both within each Institute and with new partners and the broader ecosystem should also serve to galvanize the community and catalyze the research and education activities in ways that go beyond what smaller projects could accomplish in isolation.


 

Funding Type
Internal Deadline
External Deadline
2/07/2025
Solicitation Type